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ABSTRACT
Introduction: Irritable bowel syndrome (IBS) is
characterised by symptoms such as abdominal pain,
constipation, diarrhoea and bloating. These symptoms
impact on health-related quality of life, result in excess
service utilisation and are a significant burden to
healthcare systems. Certain mechanisms which
underpin IBS can be explained by a biopsychosocial
model which is amenable to psychological treatment
using techniques such as cognitive behavioural therapy
(CBT). While current evidence supports CBT
interventions for this group of patients, access to these
treatments within the UK healthcare system remains
problematic.
Methods and analysis: A mixed methods feasibility
randomised controlled trial will be used to assess the
feasibility of a low-intensity, nurse-delivered guided
self-help intervention within secondary care
gastrointestinal clinics. A total of 60 participants will be
allocated across four treatment conditions consisting
of: high-intensity CBT delivered by a fully qualified
cognitive behavioural therapist, low-intensity guided
self-help delivered by a registered nurse, self-help only
without therapist support and a treatment as usual
control condition. Participants from each of the
intervention arms of the study will be interviewed in
order to identify potential barriers and facilitators to the
implementation of CBT interventions within clinical
practice settings. Quantitative data will be analysed
using descriptive statistics only. Qualitative data will be
analysed using a group thematic analysis.
Ethics and dissemination: This study will provide
essential information regarding the feasibility of nurse-
delivered CBT interventions within secondary care
gastrointestinal clinics. The data gathered during this
study would also provide useful information when
planning a substantive trial and will assist funding
bodies when considering investment in substantive trial
funding. A favourable opinion for this research was
granted by the Nottingham 2 Research Ethics
Committee.
Trial registration number: ISRCTN: 83683687
(http://www.controlled-trials.com/ISRCTN83683687).
BACKGROUND
Irritable bowel syndrome (IBS) is a func-
tional gastrointestinal (GI) disease that is
characterised by the presence of altered
bowel habit (diarrhoea and constipation)
and the presence of symptoms including
bloating and abdominal pain.1 The cause of
IBS remains unexplained, although it is
known that a proportion of patients will
develop IBS following an initial insult such as
GI infection.2 3 Research has also established
that food intolerance, the balance of gut
microﬂora and certain changes within the
immune system might be underlying
mechanisms in IBS.4 5 However, routine
investigations fail to identify abnormal path-
ology for IBS and patients are left with a
range of symptoms which are managed
empirically by antispasmodics, low-dose anti-
depressants and other medications. The daily
activities of patients with IBS are often
adversely affected and patients may be
troubled by concerns related to the cause
Strengths and limitations of this study
▪ This study will provide essential feasibility data
regarding the use of nurse-delivered, low-
intensity cognitive behavioural therapy (CBT)
treatment approaches with secondary care
gastrointestinal clinics.
▪ The mixed methods study design will produce
qualitative and quantitative data for analysis
which will provide a range of feasibility data.
▪ The study will not collect economic or service
use data, although this should ideally be a
concern of a follow-on study.
▪ This study does not consider the application of
other CBT treatment mechanisms such as group-
based or internet therapy.
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and the effects of their condition.6 Patients with IBS
tend to report a poor quality of life (QOL) and often
experience absenteeism.7 Moreover, IBS places a signiﬁ-
cant strain on healthcare resources and service utilisa-
tion, with patients with IBS consuming over 50% more
resources than carefully matched controls.8 9 Health pro-
fessionals may also ﬁnd themselves challenged with the
management of such a complex and persistent
disorder.10
Psychological aspects of IBS
Psychosocial factors and stress are related to the main-
tenance and manifestation of IBS symptoms in many
patients.11 Indeed, historically, clinicians felt that IBS
was purely a physical manifestation of emotional pro-
blems.12 In recent years, the association IBS has with psy-
chological issues has been supported with experimental
data. For example, Guthrie et al’s13 study involving 107
participants demonstrates that the perception of bowel
sensations may relate directly to psychological distress.
The literature reports a prevalence of psychological
comorbidity ranging anywhere between 50% and 90%
for common mental health problems such as anxiety
and depression.14 Traumatic events or stressful experi-
ences which shape an individual’s life experiences may
also play a fundamental role in IBS. Indeed, it is not
uncommon for patients with IBS to report some history
of physical or sexual abuse.15 16 Stressful life events, in
general, are associated with symptom onset and sever-
ity.17 These psychological factors and the complex mani-
festation of IBS symptoms are widely acknowledged as a
disease process which involves an individual’s social
environment, physiology and psychology.11 These ele-
ments form part of the ‘biopsychosocial model’ which
offers a holistic and rational explanation for the presen-
tation and persistence of IBS symptoms in many
individuals.
Because the mechanisms of IBS can be explained by a
biopsychosocial model, effective treatment approaches
may include psychological interventions such as cogni-
tive behavioural therapy (CBT). Best practice guidelines
suggest that CBT, hypnotherapy and psychotherapy are
useful interventions for patients with IBS.18 CBT is par-
ticularly useful for addressing negative thought patterns6
and catastrophising cognitions and avoidant beha-
viours.19 CBT can also be used to target maladaptive
thought processes20 and help patients understand the
interactions between their thoughts and their symp-
toms.21 CBT is well supported empirically as an effective
intervention for patients with IBS.22–24 Although the
Figure 1 Study flow diagram detailing numbers of participants and participant flow through the study-related procedures and
follow-up data collection periods. CBT, cognitive behavioural therapy; GSRS-IBS, Gastrointestinal Symptom Rating Scale for
irritable bowel syndrome.
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results of many of these investigations are promising, a
recent systematic review identiﬁed issues regarding the
methodological quality and power of trials which
support these interventions.25
Rationale
There is a need for CBT to be further evaluated using
robust methods.14 Furthermore, there is a need for
future research to evaluate psychological therapies
which address concerns regarding treatment provision
and accessibility.26 Many patients within the National
Health Service (NHS) healthcare system have no
routine access to psychological interventions for the
treatment of their IBS symptoms. Notwithstanding these
concerns, there is encouraging activity within the wider
UK healthcare system to suggest that the government
and policymakers are beginning to recognise the impact
that psychological therapies such as CBT have on
improving health and reducing loss of productivity.27
This study will evaluate the feasibility and acceptability
of a novel, nurse-delivered, low-intensity CBT, guided
self-help intervention for the treatment of IBS. It is
hoped that the nursing intervention will provide a feas-
ible mechanism for the delivery of CBT which may be
economically viable, more accessible to patients and
implementable within the UK healthcare system.
Qualitative research performed during the course of this
study will provide researchers and funding bodies with
essential information on the acceptability and practical
application of CBT interventions in patients with IBS.
METHODS AND ANALYSIS
Study aim
To carry out a feasibility study to explore the use of
various CBT treatment delivery mechanisms for patients
with IBS within secondary care GI clinics.
Study objectives
▸ To develop a tailored, nurse-delivered CBT treatment
for patients with IBS.
▸ To examine the number of patients needed to screen
in relation to the numbers successfully randomised
into the study.
▸ To gather reasons for patients not wishing to take
part in CBT treatment approaches for their IBS.
▸ To explore the experience of participants undergoing
the study’s treatment conditions.
▸ To identify barriers and facilitators to the implemen-
tation of the trial interventions within real clinical
settings.
▸ To measure the follow-up and response rates to study
questionnaires.
▸ To describe the range of data with relevant descrip-
tive statistics.
▸ To test the data collection procedures and time
required to collect study data.
Study design
The randomised controlled trial (RCT) is considered
one of the most powerful tools used in research to estab-
lish new knowledge claims.28 29 The proposed RCT will
establish the cause and effect relationship between CBT
and patient outcomes. A mixed methods research
(MMR) approach, underpinned by a pragmatic philoso-
phy, will draw from the strengths of qualitative and quan-
titative approaches.30 MMR is deﬁned as “collecting,
analysing and mixing both quantitative and qualitative
data in a single study or series of studies.”31 The growing
popularity of MMR approaches would suggest that many
researchers now recognise the value of this pragmatic
approach.32 MMR provides robust and rigorous
approaches to research33 and creates a richer under-
standing of phenomena.34 Many of the RCTs which have
investigated the use of CBT for patients with IBS lack a
qualitative research component. This limits our under-
standing of the suitability and acceptability of these
interventions for this group of patients. The incorpor-
ation of qualitative methods will ensure the research
considers problematic moments and meanings in indivi-
duals lives.35 These methods will also contextualise the
ﬁndings of the research36 and enable trial participants
to provide information regarding their responses to
quantitative variables.37
Patients
Around 60% of patients referred to GI clinics with lower
GI symptoms are diagnosed with IBS.38 Adults (over
18 years of age) have been chosen as the main group of
patients for inclusion as IBS is typically associated with
the third and fourth decades of life.39 In order to
ensure that participants have symptoms consistent with
IBS, they will be screened and required to fulﬁl Rome
III criteria. This tool has been developed by the Rome
Foundation with a long-standing history of development
and a strong evidence base.40 It has been successfully
utilised as symptomatic criteria for IBS in a number of
RCTs22 41 42 and is being constantly updated and
reviewed in the light of changes in the recent litera-
ture.43 Participants with symptoms inconsistent with IBS
according to Rome III criteria will be excluded from
randomisation.
Inclusion criteria
▸ Adult male and female patients aged 18 years or
older at the time of enrolment.
▸ Documented medical diagnosis of IBS.
▸ Patients with IBS which meets Rome III criteria.
▸ Able to read, write and speak English.
▸ Able to provide written informed consent.
▸ Patients with and without concomitant
antidepressant use.
▸ Able to commit to weekly treatment sessions within
the intervention arms of the study.
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Exclusion criteria
▸ Already receiving psychological therapy or
hypnotherapy.
▸ Existing diagnosis of bowel disease based on endo-
scopic or histological criteria (ie, Crohn’s disease,
ulcerative colitis, coeliac disease).
▸ Presence or history of structural or surgical diseases
of the GI tract (not including appendix or gall
bladder surgery).
▸ Evidence of alcohol or substance misuse.
▸ An established cause for bowel symptoms other than
IBS (ie, medication use).
▸ The presence of suicidal ideation or self-harm.
▸ Signiﬁcant psychiatric comorbidity (schizophrenia,
bipolar disorder, obsessive compulsive disorder).
▸ Currently taking part in other research studies.
Intervention
Many studies which have investigated the use of CBT for
patients with IBS utilise high-intensity treatment protocols.
Several RCTs have used 10-week treatment pro-
grammes,22 26 44 45 with most sessions over 50 min in dur-
ation. Some researchers have experimented with much
lower intensity treatment methods and have altered deliv-
ery mechanisms in order to improve the provision of CBT
interventions such as internet CBT.19 However, there is
concern regarding the delivery of online interventions
relating to conﬁdentiality, a loss of visual and auditory
clues during therapy and a lack of suitability for managing
crisis situations.46 A recent survey of 658 patients suggests
that internet-delivered CBTwould be unacceptable to over
40% of those surveyed.47 Other delivery mechanisms
include group-based treatments,42 although some authors
suggest that individual contact is better suited to tailoring
therapy to the needs of the client.48 CBT has been effect-
ive when delivered by trained nurses within primary care
settings.24 It is therefore possible that similar effects might
be achievable if therapy were to be delivered by GI nurses
within secondary care utilising a lower intensity, guided
self-help treatment approach which could be less time con-
suming to deliver and further increase access to evidence-
based interventions for patients.
Registered nurses working within gastroenterology are
well placed to deliver psychotherapeutic interventions to
these groups of patients as they are familiar with the
complexity of chronic GI symptoms and the impact they
have on patients and their daily activities. The prepara-
tory training utilised within this study offers a replicable
mechanism for expansion of the professional scope of
nursing practice for nurses working with the GI specialty,
while increasing access to evidence-based intervention
patients may not otherwise receive.
We have adapted the protocol and self-help materials
originally developed by Hunt et al19 at the University of
Pennsylvania USA, while working in collaboration with
service users to maximise the quality and suitability of
our nursing intervention. The nursing intervention con-
sists of an initial 60 min assessment session, with ﬁve
further 30 min treatment sessions over a 6-week treat-
ment period. Participants will work through six guided
self-help treatment modules with a nurse therapist, con-
sisting of:
▸ an introduction to IBS,
▸ relaxation training,
▸ the cognitive model of stress management,
▸ the cognitive model of IBS and behavioural
experiments,
▸ managing avoidance using exposure,
▸ diet and IBS.
The nurse therapist (ADD) undertook the ﬁrst two
modules of the National Curriculum for the education
of Psychological Wellbeing Practitioners49 in order to
prepare for the nurse therapist’s role. This training con-
sisted of 25 days of university-based teaching sessions
and simulated clinical skills training. The therapist com-
pleted all assessments for these modules to the nation-
ally accredited assessed standard, but did not access the
supervised practice hours within a mental health services
placement as this was not felt to be necessary or eco-
nomically viable for the preparation of the nurse thera-
pist’s role for the treatment of IBS.
Comparators
The nursing intervention will be compared to: (A) the
services of a fully trained and experienced cognitive
behavioural therapist using high-intensity treatment; (B)
a six module, CBT-based self-help workbook as a
stand-alone intervention; and (C) a treatment as usual
(TAU) control condition. Participants in all four treat-
ment conditions will be permitted to continue with the
routine medical management of their IBS.
Psychotherapist
Comparing the nursing intervention with the services of
a cognitive behavioural therapist during a substantive
trial will help establish whether the study’s nursing inter-
vention is as effective and acceptable as current
evidence-based treatment approaches. The psychother-
apist will deliver treatment to participants using a proto-
col developed from the work of Toner et al,48 not
dissimilar to previous trials of CBT.23 Participants will
attend 11 treatment sessions at weekly intervals, the ﬁrst
2 h in duration and subsequent sessions will last for up
to an hour.
Self-help workbooks
Participants will be given the same six module self-help
treatment workbooks as used within the nursing inter-
vention. However, in order to identify any additional
beneﬁt that the nurse therapist has within the study’s
nursing intervention, the treatment workbooks will be
used as a stand-alone treatment. Participants will be
given the workbooks by the nurse therapist and advised
that they should work through the modules on a weekly
basis. No further therapist support will be provided.
4 Dainty AD, Fox M, Lewis N, et al. BMJ Open 2014;4:e005262. doi:10.1136/bmjopen-2014-005262
Open Access
Treatment as usual
A TAU condition will enable the study of the interven-
tion in comparison to current treatment approaches and
may also be required for economic evaluations within a
deﬁnitive study. It is hoped that the feasibility study will
provide further information regarding the suitability of a
TAU control condition.
Outcomes
The literature would suggest that an extended period of
follow-up is necessary in order for researchers to estab-
lish whether the positive treatment effects of CBT dimin-
ish over time.25 However, longer follow-up periods are
not feasible within the scope of this PhD project and will
be the concern of a deﬁnitive trial. Similarly, although
an important feature of a deﬁnitive study may be a cost-
effectiveness data collection and analysis, a limitation is
that such data will not be collected during this feasibility
work. All outcome measures will be assessed at baseline,
and at 12 and 26 weeks postrandomisation. The study
ﬂow diagram (ﬁgure 1) demonstrates the various data
collection points throughout the study period.
IBS symptom severity
Numerous studies have identiﬁed the negative impact
that IBS symptoms have on QOL,50 51 and suggest that
symptoms are largely responsible for patients seeking
consultation.42 IBS symptom severity will be the primary
outcome for this study and will be measured with partici-
pant responses on the Gastrointestinal Symptom Rating
Scale for IBS (GSRS-IBS).52 GSRS-IBS consists of 13
items with ﬁve symptom subdomains including: abdom-
inal pain, bloating, diarrhoea, constipation and satiety.
Participants are asked to record the previous 7 days’
symptoms indicating responses on a seven-point Likert
scale. Mean item scores (between 1 and 7) are calcu-
lated for each of the ﬁve subdomains. Treatment respon-
ders will be deﬁned by a reduction in IBS symptom
scores of more than 50%.
Quality of life
IBS has also been shown to impact on QOL to a similar
degree as chronic conditions such as diabetes mellitus.51
Researchers have suggested that the measurement of
QOL within therapeutic trials for IBS is clearly war-
ranted.50 QOL will therefore be included as a secondary
outcome measure utilising IBS-QOL.53 IBS-QOL consists
of 34 self-report Likert scales speciﬁc to IBS. IBS-QOL
also makes possible the analysis of eight subdomains
which include: dysphoria, interference with activity, body
image, health worry, food avoidance, social reaction and
sexual relationships.
Comorbid anxiety and depression
Much of the impact that IBS has on QOL is explained
by psychological factors7 which, when treated, may
reduce IBS-related symptoms.54 Levels of depression will
be measured with the Patient Health Questionnaire
(PHQ) -9,55 and levels of anxiety using the Generalised
Anxiety Disorder (GAD)-7.56 Both of these well-validated
measures consist of nine-item and seven-item self-report
Likert scales, respectively, indicating depression and
anxiety severity scores. Necessary permissions have been
sought for all measures utilised during the conduct of
this research.
Randomisation and blinding
Participants will be allocated to one of four treatment
conditions using random permuted blocks. The princi-
pal investigator will screen all potential participants and
randomise eligible participants using an online random-
isation system (see http://www.sealedenvelope.com). All
quantitative, postintervention outcome data will be col-
lected by a research assistant blind to the allocation of
participants. The study’s investigators will be aware of
the allocation of study participants.
Sample size
This study is concerned with generating descriptive sta-
tistics that will be used to evaluate the feasibility of the
proposed methods and not to establish the effectiveness
or generalisability of the interventions. A pragmatic deci-
sion was made to randomise 60 participants across four
treatment conditions. Approximately 15 participants will
be assigned to each of the study conditions (see study
diagram).
Recruitment and participant selection
Potentially eligible clinic patients will be identiﬁed by a
member of their care team and given participant informa-
tion packs or will be sent information relating to the trial
via their hospital physician. Participants may express an
interest in taking part in the research study by returning a
reply slip using a prepaid postage service. Posters will also
be deployed on clinic and hospital notice boards. We will
also write to potentially eligible participants on our
Biomedical Research Unit research database.
Data collection
The quantitative measures will be collected by the prin-
cipal investigator (ADD) at screening and sent to partici-
pants by mail at 12 and 26 weeks postrandomisation.
Postintervention outcome data will be returned to a
research assistant blind to the allocation of participants.
Interview data will be collected by a coinvestigator (EH)
not connected to the delivery of the trial interventions.
The qualitative element of the study aims to capture
the knowledge which is located in the minds and per-
sonal experiences of others.57 Although some authors
advocate unstructured interview techniques,58 a semi-
structured approach will ensure that information relat-
ing to the phenomena of interest is obtained.59
Furthermore, the prestructure has provided a mechan-
ism for the involvement of our patient advisory group,
which has helped shape the contents of the interview
schedule. The structure and content of the interviews
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was initially developed as a result of the researcher’s
prior knowledge of GI research and the subject area as a
result of a literature review. Interview questions will be
used by the interviewer to seek clariﬁcation, illustration
and further exploration regarding important issues.60
The qualitative element of our study aims to evaluate
the experiences of service users undergoing the three
trial treatment protocols in order to identify potential
barriers and facilitators to the use of the interventions.
Five participants from each of the intervention arms of
the study will be recruited to qualitative interviews. This
study has also received ethical permission to make
enquiries into the reasons patients may have for not
taking part in the research. It will be made clear that
patients are under no obligation to provide this informa-
tion to the research team. This information will be
useful for helping researchers understand barriers to
the successful implementation of psychological therapies
for IBS within the NHS.
Data analysis
Quantitative data
Quantitative data will be analysed descriptively. Measures
of mean and variance including CIs and SD will be used
to describe the full range of data at baseline and at
follow-up. An intention to treat analysis will be facilitated
as missing data will be rectiﬁed using the last observation
carried forward. Outcome-related data will be analysed
using SPSS version 22.
Qualitative data
Corroboration will be sought between qualitative and
quantitative elements of the study.61 Qualitative data will
be generated in the form of interview transcripts for
analysis. The qualitative data will supplement the quanti-
tative outcome data by identifying convergence and dif-
ferences between the two databases.62 Interview
recordings will be transcribed verbatim prior to conduct-
ing the framework analysis advocated by Ritchie and
Spencer.63 In order to improve the rigour during the
analysis and guard against investigator bias, a group ana-
lysis approach will be used to analyse the interview tran-
scripts.64 The study’s principal investigator and the
interviewer will jointly conduct the thematic analysis of
the interview transcripts supervised by an experienced
qualitative researcher.
Patient and public involvement
Patient and public involvement (PPI) is deﬁned by the
National Institute for Health Research (NIHR) as
“research that is done with or by the public and not to,
about or for them.”65 Many awarding bodies expect to
see evidence of PPI within major grant applications.66
Our research team has developed an excellent working
alliance with a group of six patient/public volunteers
who have helped shape and improve the design of the
study. The patient advisory group has also helped to
review study documents and highlight potential barriers
to the recruitment and selection of participants. By
involving service users in the conduct of the research, it
is hoped that equilibrium has been sought in order to
address any power imbalances between health profes-
sionals and patients.67 It is also hoped that PPI has
helped maximise the quality of our nursing
intervention.
Ethical issues
Psychological issues and IBS
Although not all participants recruited for this study will
have a psychological comorbidity, some participants may
not accept, or may even reject, a psychological element
to their IBS.68 It is hoped that by conducting interviews
with study participants, barriers to the implementation
of psychological therapies relating to these phenomena
will be further explored.
Implications for participants taking part in a trial of
psychological interventions
Some participants may be concerned regarding the
implications of receiving psychotherapy during the trial.
The emphasis within our study is to focus on helping
patients to live with the impact of their IBS symptoms
rather than speciﬁcally targeting those only with psycho-
logical comorbidity (such as underlying anxiety or
depression). It will be made clear when writing to the
participant’s doctor that participation in our study does
not necessarily suggest or conﬁrm that participants are
psychologically unwell. This may be particularly import-
ant where a diagnosis of psychological illness may have
negative implications for the participant, that is, those
with rigorous occupational requirements. However,
levels of psychological illness will be recorded during a
participant’s journey through the study as we are inter-
ested in the effects that treatment may have on these
underlying issues. We will ensure that participants are
made fully aware of these issues during recruitment and
selection and that these details are included within the
study information sheets. A participant’s hospital care
team and general practitioner will be notiﬁed where a
moderate-to-severe level of anxiety or depression is
detected during measurement, as per current practice
within our GI clinics.
Host organisation approval was sought from the
Nottingham University Hospitals NHS Trust prior to the
start of any research-related activity.
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